These 3 ETFs Own Only Companies That Have Raised Dividends for 25 Years or More, and One Pays You Monthly
Not all dividend ETFs are built alike, and three funds targeting companies with decades of unbroken payout increases take wildly different approaches to turning that streak into returns for shareholders.
Investors chasing reliable dividend growth have three purpose-built exchange-traded funds that screen for one of the toughest tests on Wall Street: a track record of raising payouts every year for at least a quarter century. The ProShares S&P 500 Dividend Aristocrats ETF (BATS:NOBL) is the flagship, holding roughly 65 large caps that meet the 25-year threshold. The FT Vest S&P 500 Dividend Aristocrats Target Income ETF (BATS:KNG) owns the same universe but wraps a covered-call overlay on top and, unusual for this category, distributes income every month. The ProShares S&P MidCap 400 Dividend Aristocrats ETF (BATS:REGL) rounds out the trio as the mid-cap cousin of the Aristocrats concept.
Each fund attacks the dividend-growth thesis from a different angle: pure large-cap consistency, income enhancement through options premiums, and mid-cap compounding.
Why Aristocrat Screens Matter Now
Companies that keep raising dividends through recessions, credit crunches, and pandemics tend to share a few traits: durable free cash flow, disciplined capital allocation, and management teams that treat the payout as a promise. Screening for 25 consecutive years of increases eliminates most of the market and leaves a portfolio tilted toward consumer staples, industrials, and healthcare. That defensive skew has historically softened drawdowns while still participating in equity upside, which is why these funds have drawn steady inflows even as tech-heavy benchmarks stole the headlines.
NOBL: The Benchmark Everyone Else Is Measured Against
NOBL is the largest and most liquid Aristocrat fund, with net assets of roughly $11.1 billion as of the May 31, 2026 filing. The fund equal-weights its holdings, which prevents any single mega-cap from dominating performance and gives smaller Aristocrats like Nucor, West Pharmaceutical Services, and Franklin Resources the same voice as household names like Coca-Cola, Johnson & Johnson, and Procter & Gamble.
That structural choice matters. Equal weighting nudges the portfolio away from crowded trades and toward companies that the market has temporarily forgotten. It also produces meaningful sector diversification: industrials, consumer staples, healthcare, financials, and utilities all show up in size, alongside international-domiciled Aristocrats such as Chubb, Linde, Medtronic, and Amcor.
Performance has kept pace with what income investors expect from this category. NOBL is up about 9% year-to-date and 11% over the trailing 12 months, with a 154% total-return gain over the past decade. Distributions arrive quarterly, with a trailing 12-month payout of about $2.03 per share against a share price near $56. The tradeoff is that NOBL will not outperform sharply in a growth-led rally, and its equal-weight discipline creates modest tracking error against the S&P 500 in either direction.
KNG: Aristocrats Plus a Monthly Paycheck
KNG is the fund highlighted in the headline. It owns roughly the same S&P 500 Aristocrats universe, then sells short-dated call options on a rotating slice of the portfolio to generate premium income. Recent filings show short call positions on names like Caterpillar, ExxonMobil, Walmart, Nucor, and NextEra Energy, layered on top of the underlying equity positions. That premium gets combined with dividends and distributed monthly rather than quarterly.
The mechanics show up cleanly in the payout data. KNG has moved to a monthly cadence that has held steady through 2025 and 2026, with a trailing 12-month total of $4.21 per share and an annualized forward figure near $4.35. Against a recent price around $49, that produces a running yield materially above what a plain Aristocrat fund generates. The fund manages about $3.37 billion in net assets.
Covered calls are a real tradeoff. Selling call options caps the upside on the shares the options are written against, so KNG will tend to lag NOBL when the underlying Aristocrats rally sharply. That pattern is visible in the numbers: KNG returned about 6% year-to-date and 9% over the past year, both trailing NOBL by a couple of points. The reward is the higher, smoother monthly income stream, which is why the fund tends to appeal to retirees living off distributions and investors who value cadence over total return.
REGL: The Mid-Cap Sibling Most Screens Miss
REGL is the contrarian pick in this group. Because the mid-cap Aristocrats index uses a 15-year dividend-growth threshold rather than 25, the fund technically holds a slightly less stringent cohort. What that concession buys is exposure to businesses that have not yet been rerated as bond proxies, with more room to compound.
The portfolio, with net assets of roughly $1.68 billion, looks nothing like NOBL. Top positions include Littelfuse, Cabot, Polaris, Chemed, Reliance, and DT Midstream, alongside regional banks such as UMB Financial, Commerce Bancshares, Bank OZK, and Prosperity Bancshares. That financial and industrial tilt reflects where mid-cap dividend growth is concentrated, and it delivers a genuinely different return stream than large-cap staples.
Over five years, REGL has outrun its large-cap sibling, gaining about 48% versus NOBL’s 36%. Year-to-date returns of roughly 8% sit between the other two. Distributions are quarterly, with a trailing 12-month total near $2.03 per share against a price around $90. The caveats to consider: mid-caps carry higher volatility than large-cap staples, the fund is smaller and less liquid than NOBL, and the shallower 15-year screen means a few holdings would not qualify for the large-cap Aristocrat index.
Picking the Right Aristocrat Fund for Your Portfolio
NOBL is the default choice for most investors who want diversified exposure to dividend-growth quality with lower fees, higher liquidity, and no options-related complexity. It is the fund to own if the goal is compounding through the entire market cycle without paying much attention to it.
KNG makes sense for income-focused holders who prize monthly cash flow and are willing to give up some price appreciation to get a higher, steadier payout. Retirees replacing a paycheck are the natural buyers.
REGL belongs in portfolios that already hold a large-cap dividend fund and want to extend the same discipline down the market-cap ladder. Investors comfortable with mid-cap volatility gain access to a genuinely differentiated basket of dividend growers.
Contact [email protected] for any questions or corrections.







